USRE29324EExpiredUtility
N-Substituted aspartyl peptide amides
Priority: Apr 20, 1973Filed: Feb 5, 1976Granted: Jul 26, 1977
Est. expiryApr 20, 1993(expired)· nominal 20-yr term from priority
C07K 5/0606A61K 38/00
2
PatentIndex Score
0
Cited by
8
References
10
Claims
Abstract
Peptides containing the residues of methionine and aspartic acid are prepared by standard coupling techniques and display valuable pharmacological, e.g. gastrin-inhibitory, properties.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the formula ##STR2## wherein X is hydrogen or a tertiary-butoxycarbonyl radical, Y is a tryptophanyl radical, n is 0 or 1 and Z is an amine residue wherein the amine is an alkyl amine, cycloalkyl amine, or heterocyclic amine .[.or aralkyl amine.]..
2. As in claim 1, the compound which is N-tertiary-butoxycarbonyl-L-tryptophanyl-L-methionyl-L-α-aspartyl-DL-2'-phenylcyclopropylamide.
3. The compound N-tertiary-butoxycarbonyl-L-methionyl-L-α-aspartyl-DL-1-methylphenoxyethylamide.
4. The compound N-tertiary-butoxycarbonyl-L-tryptophanyl-L-methionyl-L-α-aspartyl-DL-1-methyl-4'-fluorophenethylamide.
5. The compound N-tertiary-butoxycarbonyl-L-tryptophanyl-L-methionyl-L-α-aspartyl-DL-1-methylphenoxyethylamide.
6. The compound L-tryptophanyl-L-methionyl-L-α-aspartyl-DL-1-methyl-4'-fluorophenethylamide.
7. The compound L-tryptophanyl-L-methionyl-L-α-aspartyl-DL-1-methylphenoxyethylamide.
8. As in claim 1, the compound which is N-tertiary-butoxycarbonyl-L-tryptophanyl-L-methionyl-L-α -aspartyl-DL-1-methylhexylamide.
9. As in claim 1, the compound which is N-tertiary-butoxycarbonyl-L-methionyl-L-α-aspartyl-2-indanylamide. .[.
10. As in claim 1, the compound which is N-tertiary-butoxycarbonyl-D-tryptophanyl-L-methionyl-L-α-aspartyl-L-1-methylphenethylamide..]. .[.11. As in claim 1, the compound which is L-tryptophanyl-L-methionyl-L-α-aspartyl-L-1-methylphenethylamide..].
2. As in claim 1, the compound which is N-tertiary-butoxycarbonyl-L-tryptophanyl-L-methionyl-L-α-aspartyl-L-
1-methylcyclohexylethylamide. 13. As in claim 1, the compound which is N-tertiary-butoxycarbonyl-L-tryptophanyl-L-methionyl-L-α-aspartyltryptamide.Join the waitlist — get patent alerts
Track USRE29324E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.